Bladder Cancer : Impact Factor & More
eISSN: 2352-3735pISSN: 2352-3727
Share this on:
Key Metrics
CiteScore 
3.1
Impact Factor
< 5
SJR
Q3Urology
SNIP
0.63
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Bladder Cancer
Bladder Cancer Journal Specifications
| Overview | |
| Publisher | IOS PRESS |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2015 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Bladder Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Bladder Cancer
Development of an extended version of GALEAS bladder: Detection of FGFR3 fusions in urine and associations between genomic alterations and gene expression.
- 5 May 2026
- Bladder cancer (Amsterdam, Netherlands)
Patterns of care and associated social determinants of health in the definitive treatment of localized muscle-invasive bladder cancer patients.
- 13 Apr 2026
- Bladder cancer (Amsterdam, Netherlands)
Treatment patterns and outcomes with second-line therapies in patients with advanced urothelial carcinoma previously treated with first-line enfortumab vedotin with pembrolizumab
- 29 Mar 2026
- Bladder Cancer
Adjuvant immunotherapy for muscle-invasive urothelial carcinoma: Considerations for targeting patients
- 1 Mar 2026
- Bladder Cancer
Analysis of sarcopenia indicators on survival prediction undergoing radical cystectomy
- 1 Mar 2026
- Bladder Cancer
Circulating tumor DNA-guided adjuvant immunotherapy in muscle-invasive bladder cancer.
- 1 Feb 2026
- Bladder cancer (Amsterdam, Netherlands)
Development of an extended version of GALEAS bladder: Detection of FGFR3 fusions in urine and associations between genomic alterations and gene expression.
- 5 May 2026
- Bladder cancer (Amsterdam, Netherlands)
Patterns of care and associated social determinants of health in the definitive treatment of localized muscle-invasive bladder cancer patients.
- 13 Apr 2026
- Bladder cancer (Amsterdam, Netherlands)
Treatment patterns and outcomes with second-line therapies in patients with advanced urothelial carcinoma previously treated with first-line enfortumab vedotin with pembrolizumab
- 29 Mar 2026
- Bladder Cancer
Adjuvant immunotherapy for muscle-invasive urothelial carcinoma: Considerations for targeting patients
- 1 Mar 2026
- Bladder Cancer
Analysis of sarcopenia indicators on survival prediction undergoing radical cystectomy
- 1 Mar 2026
- Bladder Cancer
Circulating tumor DNA-guided adjuvant immunotherapy in muscle-invasive bladder cancer.
- 1 Feb 2026
- Bladder cancer (Amsterdam, Netherlands)
FAQs on Bladder Cancer
How long has Bladder Cancer been actively publishing? 
What is the publishing frequency of Bladder Cancer?
How many articles did Bladder Cancer publish last year?
What is the eISSN & pISSN for Bladder Cancer?
What is Citescore for Bladder Cancer?
What is SNIP score for Bladder Cancer?
What is the SJR for Bladder Cancer?
Who is the publisher of Bladder Cancer?
